Neurological Oncology
EUROPEAN PARTNER
An Introduction to Neurological Oncology
Neurological oncology is a rapidly evolving field, encompassing diagnosis and management of primary and metastatic tumours of the CNS, and complications of systemic cancers or cancer treatment. Neuroimaging advances have allowed accurate screening for intracranial disease at initial cancer diagnosis, precise targeting of intracranial lesions during treatment, and differentiation of treatment effects from disease progression by incorporating functional imaging. Our ability to achieve total resection of gliomas has improved significantly. Other advances include tumour-treating fields; hippocampal-sparing whole-brain radiotherapy (WBRT); WBRT with memantine; parotid-sparing WBRT; use of artificial intelligence with stereotactic radiotherapy; and systemically delivered immunotherapies, including vaccines and immune checkpoint inhibitors.
Browse our gallery of video highlights and short articles from the conference hub, providing latest expert insights from major conferences and peer-reviewed articles from the journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
In this episode, we’re joined by Bradley Love, Professor of Cognitive and Decision Sciences at UCL, ELLIS fellow, and creator of BrainGPT. We discuss how this large language model is poised to assist researchers in advancing their work.
Brain metastases (BM) are the most frequent among intracranial brain tumours and their incidence is rising as therapeutic advances are improving the survival of patients with advanced cancer. The incidence of BM has been calculated as 9–17% based on various studies, ...
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
